Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Centene Corporation

U.S. stocks ended the week lower as pressure from rates and commodities weighed on risk appetite. The Dow Jones Industrial Average (DJIA) fell 0.36...

The Week That Was, The Week Ahead: Macro and Markets, Feb. 1

In a report released on January 26, Bart Dziarski from RBC Capital maintained a Hold rating on ECN Capital, with a price target of C$3.10. The comp...

RBC Capital Sticks to Its Hold Rating for ECN Capital (ECN)

Bernstein analyst Lance Wilkes maintained a Buy rating on Centene today and set a price target of $59.00. According to TipRanks, Wilkes is a 2-star...

Centene (CNC) Receives a Buy from Bernstein

Analysts have been eager to weigh in on the Financial sector with new ratings on First Citizens BancShares (FCNCA – Research Report) and Freddie Ma...

Analysts Have Conflicting Sentiments on These Financial Companies: First Citizens BancShares (FCNCA) and Freddie Mac (OtherFMCC)

First Citizens BancShares, Inc. Class A (($FCNCA)) has held its Q4 earnings call. Read on for the main highlights of the call. First Citizens BancS...

First Citizens BancShares Earnings Call: Growth Amid Pressure

First Citizens BancShares ( ($FCNCA) ) has shared an update. First Citizens BancShares reported solid fourth-quarter 2025 performance, with net inc...

First Citizens BancShares Posts Strong Q4 2025 Results

The latest announcement is out from ECN Capital ( ($TSE:ECN) ). ECN Capital Corp. has secured final court approval from the Ontario Superior Court ...

ECN Capital Wins Final Court Nod for Warburg Pincus–Led Takeover

In a report released yesterday, from Berenberg Bank initiated coverage with a Buy rating on Concurrent Technologies and a price target of p275.00. ...

Concurrent Technologies (CNC) Initiated with a Buy at Berenberg Bank

ECN Capital ( ($TSE:ECN) ) just unveiled an announcement. Shareholders of ECN Capital Corp. have approved a plan of arrangement under which a newly...

ECN Capital Shareholders Back Warburg Pincus-Led Takeover

In a report released on January 16, Lance Wilkes from Bernstein maintained a Buy rating on Centene, with a price target of $59.00. The company’s sh...

U.S. stocks finished the week essentially flat as a semiconductor-led bid was offset by softer bank performance and a steady drumbeat of policy hea...

The Week That Was, The Week Ahead: Macro and Markets, Jan. 18

Analysts have been eager to weigh in on the Healthcare sector with new ratings on 4D Molecular Therapeutics (FDMT – Research Report), Centene (CNC ...

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Centene (CNC) and Cencora (COR)

Jefferies analyst David Windley maintained a Hold rating on Centene today and set a price target of $43.00. Windley covers the Healthcare sector, f...

Jefferies Remains a Hold on Centene (CNC)

Coincheck Group ( ($CNCK) ) has shared an update. On January 6, 2026, Coincheck Group filed a Form 6-K providing a preliminary monthly performance ...

Coincheck Group Reports Unaudited 2025 Monthly Metrics, Highlighting Continued Account Growth

In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on Centene, with a price target of $59.00. According to TipRanks, W...

Bernstein Remains a Buy on Centene (CNC)

Barclays analyst Jason Goldberg maintained a Hold rating on First Citizens BancShares today and set a price target of $2,456.00. According to TipRa...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CNC	$42.51	-0.68%	3.83M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CNC	$42.51	-0.7%	3.83M
3
4
5
6

CNC

CNC

No Data Available

Get Centene Corporation Data in Excel

Get Centene Corporation Data in Excel